Drug intelligence / Profile preview

hydrocortisone + bacitracin + colistin

Development stage
Unknown
Lead developer
Julius Center for Health Sciences and Primary Care
Modality
Peptides, Small Molecules
Administration
Otic
01

Overview

Hydrocortisone + bacitracin + colistin is a topical otic combination formulation consisting of a corticosteroid and two antibiotics. Hydrocortisone serves as an anti-inflammatory agent to reduce swelling and pain in the ear canal. Bacitracin is a polypeptide antibiotic that inhibits bacterial cell wall synthesis by binding to undecaprenyl pyrophosphate, while colistin is a polymyxin antibiotic that disrupts bacterial cell membranes by binding to lipopolysaccharides. This combination is primarily used for the treatment of acute otitis media with ear discharge (AOMd) and otorrhea, targeting pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, and *Pseudomonas aeruginosa*. It is notably used in the Netherlands and France, often as an alternative to oral antibiotics or aminoglycoside-containing eardrops to avoid potential ototoxicity.

Brand names
Bacicoline-B
Other names
hydrocortisone-bacitracin-colistin eardrops
02

Targets

GR (Glucocorticoid receptor)UPP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on hydrocortisone + bacitracin + colistin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + bacitracin + colistin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call